HomeNews

News

  • Botox shows efficacy in Multiple Sclerosis urinary symptoms

    • August 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Marijuana-Based Epilepsy Drug, Epidiolex priced at $32,500 for a Year

    • August 10, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Sanofi launches multiple sclerosis drug Aubagio in India

    • August 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Boehringer Ingelheim to Develop novel Gene Therapy for Cystic Fibrosis

    • August 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Positive Clinical Results announced for LRRK2 in Parkinson’s Disease

    • August 6, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • FDA Approves Perseris (risperidone) for Schizophrenia treatment in Adults

    • August 6, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Novartis wins Aimovig approval for launch in the EU markets

    • August 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Genkyotex announces Ph 2 trial for GKT831 in Patients with IPF

    • August 3, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Roche receives FDA’s breakthrough status for its new Alzheimer’s biomarker

    • July 25, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Bill Gates invests $30m on affordable Alzheimer’s test

    • July 20, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more